Literature DB >> 33311702

Individual and community-level risk for COVID-19 mortality in the United States.

Jin Jin1, Neha Agarwala2, Prosenjit Kundu1, Benjamin Harvey1, Yuqi Zhang3, Eliza Wallace4, Nilanjan Chatterjee5,6.   

Abstract

Reducing COVID-19 burden for populations will require equitable and effective risk-based allocations of scarce preventive resources, including vaccinations1. To aid in this effort, we developed a general population risk calculator for COVID-19 mortality based on various sociodemographic factors and pre-existing conditions for the US population, combining information from the UK-based OpenSAFELY study with mortality rates by age and ethnicity across US states. We tailored the tool to produce absolute risk estimates in future time frames by incorporating information on pandemic dynamics at the community level. We applied the model to data on risk factor distribution from a variety of sources to project risk for the general adult population across 477 US cities and for the Medicare population aged 65 years and older across 3,113 US counties, respectively. Validation analyses using 54,444 deaths from 7 June to 1 October 2020 show that the model is well calibrated for the US population. Projections show that the model can identify relatively small fractions of the population (for example 4.3%) that might experience a disproportionately large number of deaths (for example 48.7%), but there is wide variation in risk across communities. We provide a web-based risk calculator and interactive maps for viewing community-level risks.

Entities:  

Year:  2020        PMID: 33311702     DOI: 10.1038/s41591-020-01191-8

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  17 in total

1.  Association of AKI-D with Urinary Findings and Baseline eGFR in Hospitalized COVID-19 Patients.

Authors:  Dipal M Patel; Manali Phadke; Feng Dai; Michael Simonov; Neera K Dahl; Ravi Kodali
Journal:  Kidney360       Date:  2021-05-20

2.  COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry.

Authors:  Meryl Waldman; Maria Jose Soler; Clara García-Carro; Liz Lightstone; Tabitha Turner-Stokes; Megan Griffith; Joan Torras; Laura Martinez Valenzuela; Oriol Bestard; Colin Geddes; Oliver Flossmann; Kelly L Budge; Chiara Cantarelli; Enrico Fiaccadori; Marco Delsante; Enrique Morales; Eduardo Gutierrez; Jose A Niño-Cruz; Armando J Martinez-Rueda; Giorgia Comai; Claudia Bini; Gaetano La Manna; Maria F Slon; Joaquin Manrique; Alejandro Avello; Raul Fernandez-Prado; Alberto Ortiz; Smaragdi Marinaki; Carmen Rita Martin Varas; Cristina Rabasco Ruiz; Milagros Sierra-Carpio; Rebeca García-Agudo; Gema Fernández Juárez; Alexander J Hamilton; Annette Bruchfeld; Constantina Chrysochou; Lilian Howard; Smeeta Sinha; Tim Leach; Irene Agraz Pamplona; Umberto Maggiore; Paolo Cravedi
Journal:  Kidney360       Date:  2021-12-03

3.  Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia.

Authors:  Tatjana Meister; Heti Pisarev; Raivo Kolde; Ruth Kalda; Kadri Suija; Lili Milani; Liis Karo-Astover; Marko Piirsoo; Anneli Uusküla
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

4.  Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines.

Authors:  Anna Flor G Malundo; Cybele Lara R Abad; Maria Sonia S Salamat; Joanne Carmela M Sandejas; Jonnel B Poblete; Jose Eladio G Planta; Shayne Julieane L Morales; Ron Rafael W Gabunada; Agnes Lorrainne M Evasan; Johanna Patricia A Cañal; Julian A Santos; Jeffrey T Manto; Maria Elizabeth P Mercado; Raniv D Rojo; Eric David B Ornos; Marissa M Alejandria
Journal:  IJID Reg       Date:  2022-07-14

5.  The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19.

Authors:  M Fathi; F Taghizadeh; H Mojtahedi; S Zargar Balaye Jame; N Markazi Moghaddam
Journal:  Rev Neurol (Paris)       Date:  2021-09-13       Impact factor: 4.313

6.  Using Statewide Electronic Health Record and Influenza Vaccination Data to Plan and Prioritize COVID-19 Vaccine Outreach and Communications in Wisconsin Communities.

Authors:  Jessica Bonham-Werling; Allie J DeLonay; Kristina Stephenson; Korina A Hendricks; Lauren Bednarz; Jennifer M Weiss; Matthew Gigot; Maureen A Smith
Journal:  Am J Public Health       Date:  2021-12       Impact factor: 9.308

7.  Factors Associated With COVID-19 Death in the United States: Cohort Study.

Authors:  Uan-I Chen; Hua Xu; Trudy Millard Krause; Raymond Greenberg; Xiao Dong; Xiaoqian Jiang
Journal:  JMIR Public Health Surveill       Date:  2022-05-12

8.  Data-Driven Decision Making and Proactive Citizen-Scientist Communication: A Cross-Sectional Study on COVID-19 Vaccination Adherence.

Authors:  Emil Syundyukov; Martins Mednis; Linda Zaharenko; Eva Pildegovica; Ieva Danovska; Svjatoslavs Kistkins; Abraham Seidmann; Arriel Benis; Valdis Pirags; Lilian Tzivian
Journal:  Vaccines (Basel)       Date:  2021-11-24

9.  Assessing community-level COVID-19 infection risk through three-generational household concentration in Nebraska, U.S.: An approach for COVID-19 prevention.

Authors:  Dong Liu; Ge Lin; Han Liu; Dejun Su; Ming Qu; Yi Du
Journal:  Prev Med Rep       Date:  2022-01-19

10.  Impact of Dementia on Mortality Due to Coronavirus Disease 2019: Propensity-Score-Matching Study.

Authors:  Jin Pyeong Jeon; Su Jung Lee; Chulho Kim
Journal:  J Clin Neurol       Date:  2022-01       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.